← Back to catalogue

BinaxNOW COVID-19/Flu A&B Combo Self Test

FDA UDI

Class II (US FDA UDI)

by Alere Scarborough, Inc.

Identity

Trade Name
BinaxNOW COVID-19/Flu A&B Combo Self Test FDA UDI
Generic Name
Multiple-genus respiratory virus antigen IVD, kit, rapid ICT, self-testing FDA UDI
Device Name
Intended for detection of proteins from Influenza A, Influenza B and SARS-CoV-2, not for any other viruses or pathogens FDA UDI
Model / Reference
20002051 FDA UDI
Description
Intended for detection of proteins from Influenza A, Influenza B and SARS-CoV-2, not for any other viruses or pathogens FDA UDI

Identifiers

Primary DI / UDI-DI
00811877012054 FDA UDI
FDA Product Code
SCA FDA UDI
GMDN Term
Multiple-genus respiratory virus antigen IVD, kit, rapid ICT, self-testing FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
866.3987 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

No

FDA UDI

Over-the-Counter

Yes

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Multiple-genus respiratory virus antigen IVD, kit, rapid ICT, self-testing

BinaxNOW COVID-19/Flu A&B Combo Self Test by Alere Scarborough, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Multiple-genus respiratory virus antigen IVD, kit, rapid ICT, self-testing.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 5856f971-c653-4db3-b69a-19aed7f0b245 33 fields · synced Jun 6, 2026